Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Clinical and Economic Implications of AF Related Stroke.

Ali AN, Abdelhafiz A.

J Atr Fibrillation. 2016 Feb 29;8(5):1279. doi: 10.4022/jafib.1279. eCollection 2016 Feb-Mar. Review.

2.

Cost-effectiveness analysis of left atrial appendage occlusion compared with pharmacological strategies for stroke prevention in atrial fibrillation.

Lee VW, Tsai RB, Chow IH, Yan BP, Kaya MG, Park JW, Lam YY.

BMC Cardiovasc Disord. 2016 Aug 31;16(1):167. doi: 10.1186/s12872-016-0351-y.

3.

European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial Fibrillation.

Li CH, Liu CJ, Chou AY, Chao TF, Tuan TC, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Chung FP, Liao JN, Chen TJ, Wu TJ, Chen SA.

Sci Rep. 2016 Aug 8;6:30734. doi: 10.1038/srep30734.

4.

Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.

Freeman JV, Hutton DW, Barnes GD, Zhu RP, Owens DK, Garber AM, Go AS, Hlatky MA, Heidenreich PA, Wang PJ, Al-Ahmad A, Turakhia MP.

Circ Arrhythm Electrophysiol. 2016 Jun;9(6). pii: e003407. doi: 10.1161/CIRCEP.115.003407.

5.

Cost-effectiveness of anticoagulation in patients with nonvalvular atrial fibrillation with edoxaban compared to warfarin in Germany.

Krejczy M, Harenberg J, Wehling M, Obermann K, Lip GY.

Biomed Res Int. 2015;2015:876923. doi: 10.1155/2015/876923. Epub 2015 Mar 17.

6.

Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making.

Eckman MH, Wise RE, Naylor K, Arduser L, Lip GY, Kissela B, Flaherty M, Kleindorfer D, Khan F, Schauer DP, Kues J, Costea A.

Curr Med Res Opin. 2015 Apr;31(4):603-14. doi: 10.1185/03007995.2015.1019608. Epub 2015 Mar 13.

7.

Patient values and preferences when choosing anticoagulants.

Palacio AM, Kirolos I, Tamariz L.

Patient Prefer Adherence. 2015 Jan 22;9:133-8. doi: 10.2147/PPA.S64295. eCollection 2015.

8.

Cost-effectiveness of clopidogrel-aspirin versus aspirin alone for acute transient ischemic attack and minor stroke.

Pan Y, Wang A, Liu G, Zhao X, Meng X, Zhao K, Liu L, Wang C, Johnston SC, Wang Y, Wang Y; CHANCE Investigators.

J Am Heart Assoc. 2014 Jun 5;3(3):e000912. doi: 10.1161/JAHA.114.000912.

9.
10.

Potential impact of new oral anticoagulants on the management of atrial fibrillation-related stroke in primary care.

Harris K, Mant J.

Int J Clin Pract. 2013 Jul;67(7):647-55. doi: 10.1111/ijcp.12177. Epub 2013 Apr 28. Review.

11.

Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillation.

Lee S, Mullin R, Blazawski J, Coleman CI.

PLoS One. 2012;7(10):e47473. doi: 10.1371/journal.pone.0047473. Epub 2012 Oct 9.

12.

A pilot randomized controlled trial of a decision support tool to improve the quality of communication and decision-making in individuals with atrial fibrillation.

Fraenkel L, Street RL Jr, Towle V, O'Leary JR, Iannone L, Van Ness PH, Fried TR.

J Am Geriatr Soc. 2012 Aug;60(8):1434-41. doi: 10.1111/j.1532-5415.2012.04080.x. Epub 2012 Aug 2.

13.

Cost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillation.

You JH, Tsui KK, Wong RS, Cheng G.

PLoS One. 2012;7(6):e39640. doi: 10.1371/journal.pone.0039640. Epub 2012 Jun 22.

14.

Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

MacLean S, Mulla S, Akl EA, Jankowski M, Vandvik PO, Ebrahim S, McLeod S, Bhatnagar N, Guyatt GH.

Chest. 2012 Feb;141(2 Suppl):e1S-e23S. doi: 10.1378/chest.11-2290. Review.

15.

Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study.

Alonso-Coello P, Montori VM, Solà I, Schünemann HJ, Devereaux P, Charles C, Roura M, Díaz MG, Souto JC, Alonso R, Oliver S, Ruiz R, Coll-Vinent B, Diez AI, Gich I, Guyatt G.

BMC Health Serv Res. 2008 Oct 27;8:221. doi: 10.1186/1472-6963-8-221.

16.

Professional centred shared decision making: patient decision aids in practice in primary care.

Watson DB, Thomson RG, Murtagh MJ.

BMC Health Serv Res. 2008 Jan 11;8:5. doi: 10.1186/1472-6963-8-5.

17.

A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial.

Thomson RG, Eccles MP, Steen IN, Greenaway J, Stobbart L, Murtagh MJ, May CR.

Qual Saf Health Care. 2007 Jun;16(3):216-23.

18.

Using decision aids to help patients navigate the "grey zone" of medical decision-making.

O'Connor AM.

CMAJ. 2007 May 22;176(11):1597-8. No abstract available.

19.

The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden.

Björholt I, Andersson S, Nilsson GH, Krakau I.

BMC Fam Pract. 2007 Feb 26;8:6.

20.

Medical communication and technology: a video-based process study of the use of decision aids in primary care consultations.

Kaner E, Heaven B, Rapley T, Murtagh M, Graham R, Thomson R, May C.

BMC Med Inform Decis Mak. 2007 Jan 10;7:2.

Supplemental Content

Support Center